On August 26, 2019 Audentes Therapeutics, Inc. (Nasdaq: BOLD), a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases, reported that it will participate in the following investor conferences in September (Press release, Audentes Therapeutics, AUG 26, 2019, View Source [SID1234538974]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Citi’s 14th Annual Biotech Conference
Matthew R. Patterson, Chariman and Chief Executive Officer
Format: 1×1 Investor Meetings
Wednesday, September 4, 2019 – Thursday, September 5, 2019
Boston, Massachusetts
Morgan Stanley 17th Annual Global Healthcare Conference
Natalie Holles, President and Chief Operating Officer
Format: Fireside Chat
Monday, September 9, 2019, at 11:05 am ET
New York, New York
To access the live webcast of the Morgan Stanley fireside chat, please visit the Events & Presentations page within the Investors + Media section of the Audentes website. Following the conference, a replay of the live webcast will be available on the Audentes website for approximately 30 days.